Overview

Vasopressor Infusion in Cesarean Delivery

Status:
Recruiting
Trial end date:
2022-03-10
Target enrollment:
Participant gender:
Summary
Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.
Phase:
Phase 4
Details
Lead Sponsor:
Cairo University
Treatments:
Bupivacaine
Norepinephrine
Oxymetazoline
Phenylephrine